PRO96 A Multi-Stakeholder Multicriteria Decision Analysis in Rare Diseases: Reimbursement Criteria for Orphan Drugs in Spain (FinMHU-MCDA study)
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI